Search for: "Teva Pharmaceuticals USA, Inc." Results 281 - 300 of 489
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Differentiating patent attorneys
11 Dec 2008, 10:30 pm
(DRL); and Teva Pharmaceuticals USA, Inc. [read post]
IPBiz - http://ipbiz.blogspot.com/
Blog Post: Tightening the Belt on Skinny Labels
18 Dec 2023, 10:00 pm by Sherica Celine
USA, Inc. , 7 F.4th 1320 (Fed. [read post]
Legal Insights Blog - https://www.lexisnexis.com/community/insights/legal/
Federal Circuit Affirms Skinny Label Carve Outs
18 Jan 2024, 9:16 am by Fred Chung, Bradley Graveline and James Hurt
Teva Pharmaceuticals USA, Inc., 7 F.4th 1320, 1333 (Fed. [read post]
Intellectual Property Law Blog - http://www.intellectualpropertylawblog.com/
Pharma & Biotech Global Week in Review 13 October 2010 from IP Think Tank
12 Oct 2010, 8:56 pm by Kelly
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Sunovion wins appeal from DNJ at CAFC in eszopiclone [Lunesta] case
27 Sep 2013, 5:47 am by Lawrence B. Ebert
USA, Inc., No. 09-1302(D.N.J. [read post]
IPBiz - http://ipbiz.blogspot.com/
First Dust Up Over Generic PROVIGIL 180-Day Exclusivity Quickly Put on Hold With TRO/PI Motion Withdrawal, But is Followed Up With a Second Lawsuit
5 Apr 2012, 1:41 pm by FDABlog HPM
Karst –       It was yet another exciting day in the Hatch-Waxman world when news broke Wednesday morning that Teva Pharmaceuticals USA, Inc. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Defendant Preliminarily Enjoined from Releasing Generic EVISTA ® Despite Challenges to Validity and Enforceability of Plaintiff's Patents
24 Apr 2009, 1:04 am
TEVA PHARMACEUTICALS USA, INC., 1-06-cv-01017 (INSD April 22, 2009, Order) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
The Use of Mandated Public Disclosures of Clinical Trials as Prior Art Against Study Sponsors
16 Apr 2024, 8:42 am by Holman
USA, Inc., 2023 WL 3335538 (Fed. [read post]
Patently-O - https://patentlyo.com
Low Testosterone Medications and Gels – Increased Risk of Non-fatal Myocardial Infarction?
13 Feb 2014, 8:36 am by m zamora
– topical gel applied to the skinAxiron (Lilly USA, LLC) – topical cream applied to underarmBio-T-Gel (Teva Pharmaceuticals) – topical gel applied to skinDelatestryl (Endo Pharmaceuticals) – injection or solutionDepo-Testosterone (Unigen Life Sciences) – injection solutionFortesta (Endo Pharmaceuticals) – topical gel applied to skinStriant (Auxilium Pharmaceuticals) – buccal… [read post]
A Georgia Lawyer - http://ageorgialawyer.blogspot.com/
“Product Hopping” Antitrust Lawsuit Takes on a Heightened Profile with Proposed FTC Amicus Brief
25 Nov 2012, 5:42 pm by FDABlog HPM
USA, Inc., 432 F. [read post]
FDA Law Blog - http://www.fdalawblog.net/fda_law_blog_hyman_phelps/
Supreme Court Rules That Even “Secret Sales” Can Place An Invention “On-Sale” Under the AIA
23 Jan 2019, 12:13 pm by Rachel Sandler
Teva Pharmaceuticals USA Inc. [read post]
Volpe and Koenig IP Law Blog - http://vklaw.com/category/blog/
Anti-Bartlett Arguments
27 Dec 2012, 3:47 pm by Bexis
Teva Pharmaceuticals USA, Inc., 2012 WL 1866839, at *5 (W.D. [read post]
Drug and Device Law - http://druganddevicelaw.blogspot.com/
NILL added new content to the Indian Law Bulletins on 4/18
18 Apr 2019, 1:57 pm by Unknown
Teva Pharmaceuticals USA, Inc. [read post]
National Indian Law Library -- News - http://nilllibrary.blogspot.com/
NILL added new content to the Indian Law Bulletins on 6/5
5 Jun 2019, 2:37 pm by Unknown
Teva Pharmaceuticals USA, Inc. [read post]
National Indian Law Library -- News - http://nilllibrary.blogspot.com/
NILL added new content to the Indian Law Bulletins on 6/5
5 Jun 2019, 2:37 pm by Unknown
Teva Pharmaceuticals USA, Inc. [read post]
National Indian Law Library -- News - http://nilllibrary.blogspot.com/
NILL added new content to the Indian Law Bulletins on 4/18
18 Apr 2019, 1:57 pm by Native American Rights Fund
Teva Pharmaceuticals USA, Inc. [read post]
National Indian Law Library -- News - http://nilllibrary.blogspot.com/
Pharma & Biotech Global Week in Review 8 September 2010 from IP Think Tank
7 Sep 2010, 6:10 pm by Kelly
Highlights this week included: CAFC: Disclosure that merely allows PHOSITA to ‘envision’ the claimed invention fails written description: Goeddel v Sugano (Peter Zura’s 271 Patent Blog) (Patently-O) (Patent Prospector) Evista (Raloxifene) – US: CAFC upholds decision against Teva: Eli Lilly & Co v Teva Pharmaceuticals USA, Inc (Patent Docs) (The IP Factor) Aranesp (Darbepoetin) – EU: ECJ says ‘no’ to Kirin… [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Pharma & Biotech Global Week in Review 29 September 2010 from IP Think Tank
28 Sep 2010, 3:14 pm by Kelly
Teva Pharmaceuticals USA Inc. et al. [read post]
IP Thinktank - http://duncanbucknell.com/ipthinktank.blog
Safe Harbor Provision for Divisional Patent Applications
8 Oct 2009, 12:37 pm by James Yang
Teva Pharmaceuticals USA, Inc. 518 F.3d 1353 (Fed. [read post]
OC Patent Lawyer - http://ocpatentlawyer.com
Defendants' Persistence in Pursuing "Baseless Inequitable Conduct Claim" Justified Award of Attorneys' Fees to Plaintiff
20 Oct 2011, 7:18 am by The Docket Navigator
Teva Pharmaceuticals USA, Inc., et. al., 2-10-cv-00128 (VAED October 17, 2011, Order) (Smith, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/